IN8bio Inc.

INAB | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.09

+$0.01 (+0.93%)

At close: Sep 21, 2026, 3:59 PM ET

$1.06

-$0.03 (-2.75%)

After-hours: Sep 21, 2026, 4:10 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $10.36M

Enterprise Value $-5.33M

Beta 0.30

Average Volume 59.77K

Shares Outstanding (Diluted) 19.47M

Shares Change YoY 372.6%

Institutional Ownership 19.28%

Exchange NASDAQ

ISIN US45674E2081

Price Performance

Price Change 1M -16.1%

Price Change 3M -25.3%

Price Change 6M -32.3%

Price Change YTD -55.7%

Price Change 1Y -48.3%

Price Change 3Y -97.0%

Price Change 5Y -99.5%

1M CAGR (ann.) 11.3%

1Y CAGR (ann.) -46.0%

5Y CAGR (ann.) -66.8%

All-Time CAGR -66.5%

Valuation

PE Ratio -0.39

Forward PE N/A

PEG Ratio -0.00

Forward PEG 0.04

PS Ratio N/A

Forward PS 6.30

PB Ratio 0.57

P/FCF Ratio -0.72

P/Adj. FCF Ratio -0.62

P/OCF Ratio -1.47

EV/Sales N/A

EV/EBIT 0.38

EV/EBITDA 0.31

EV/FCF 0.36

Earnings Yield -254.1%

FCF Yield -139.7%

Adj. FCF Yield -160.3%

Financial Health

Net Cash $15.78M

Total Debt $2.18M

Cash & Short-Term Investments $17.96M

Total Assets $21.75M

Current Ratio 8.21

Quick Ratio 8.21

Debt / Equity Ratio 0.12

Debt / EBITDA -0.13

Debt / FCF -0.15

OCF / Debt -6.59

Interest Coverage 0.00

Altman Z-Score -9.11

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -14.8%

Returns

Return on Assets -85.8%

Return on Equity -91.2%

Return on Invested Capital -91.7%

Return on Capital Employed -96.7%

Return on Tangible Assets -85.8%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -56.6%

EPS CAGR 5Y -22.8%

EPS CAGR 10Y N/A

FCF CAGR 3Y 27.2%

FCF CAGR 5Y 6.2%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 4

EPS Growth Next 3Y 37.2%

Revenue Growth Next 3Y N/A

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$0.34

EPS Growth Est (next Q) -60.4%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $4

Price Target Upside 267.0%

Cash Flow

Operating Cash Flow $-14.36M

Free Cash Flow $-14.6M

Adj. Free Cash Flow $-16.75M

FCF Per Share -$0.75

OCF Per Share -$0.74

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-500K

Operating Income $-18.84M

EBITDA $-17.21M

Net Income $-18.67M

EPS (Diluted) -$2.77

Revenue / Employee N/A

Profit / Employee $-1.04M

Employees 18